These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29575350)

  • 21. Regulatory T cells in immune-mediated renal disease.
    Ghali JR; Wang YM; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T cells: a review.
    Dasgupta A; Saxena R
    Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs.
    Mayer CT; Huntenburg J; Nandan A; Schmitt E; Czeloth N; Sparwasser T
    J Autoimmun; 2013 Dec; 47():73-82. PubMed ID: 24055067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
    Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
    Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells and T cells in the regulation of cutaneous immunity.
    Loser K; Beissert S
    Adv Dermatol; 2007; 23():307-33. PubMed ID: 18159907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How specificity for self-peptides shapes the development and function of regulatory T cells.
    Simons DM; Picca CC; Oh S; Perng OA; Aitken M; Erikson J; Caton AJ
    J Leukoc Biol; 2010 Dec; 88(6):1099-107. PubMed ID: 20495071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome].
    Bernard F; Romano A; Granel B
    Rev Med Interne; 2010 Feb; 31(2):116-27. PubMed ID: 19962219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
    Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
    Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells.
    Namdari H; Izad M; Rezaei F; Amirghofran Z
    Int Immunopharmacol; 2019 Feb; 67():417-426. PubMed ID: 30586665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Yin and Yang of regulatory T cell and therapy progress in autoimmune disease.
    Qiao YC; Pan YH; Ling W; Tian F; Chen YL; Zhang XX; Zhao HL
    Autoimmun Rev; 2017 Oct; 16(10):1058-1070. PubMed ID: 28778708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
    Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R
    Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foxp3 expressing regulatory T-cells in allergic disease.
    Nouri-Aria KT
    Adv Exp Med Biol; 2009; 665():180-94. PubMed ID: 20429425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD80CD86 deficiency disrupts regulatory CD4+FoxP3+T cell homoeostasis and induces autoimmune-like alopecia.
    Bae JH; Hwang WS; Jang YJ; Lee YH; Jang DE; Kim JS; Yeom SC
    Exp Dermatol; 2017 Nov; 26(11):1053-1059. PubMed ID: 28423200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
    Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
    Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
    Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.
    Miyara M; Sakaguchi S
    Immunol Cell Biol; 2011 Mar; 89(3):346-51. PubMed ID: 21301480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.